FDA finalizes best practices guide for postmarketing safety studies
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesPharmaceuticalsPharmacovigilanceUnited StatesRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesPharmaceuticalsPharmacovigilanceUnited States